Article Cited by others


Metronomic chemotherapy

Maiti Rituparna

Year : 2014| Volume: 5| Issue : 3 | Page no: 186-192

   This article has been cited by
1 Enhanced treatment of lung cancer by metronomic therapy with oral pemetrexed
Kinam Park
Journal of Controlled Release. 2018; 284: 250
[Pubmed]  [Google Scholar] [DOI]
2 Potentiating cancer vaccine efficacy in liver cancer
Maria Tagliamonte,Annacarmen Petrizzo,Angela Mauriello,Maria Lina Tornesello,Franco M Buonaguro,Luigi Buonaguro
OncoImmunology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?
Marina E. Cazzaniga,Elisabetta Munzone,Emilia Montagna,Giovanni Pappagallo
Expert Review of Anticancer Therapy. 2018; 18(8): 805
[Pubmed]  [Google Scholar] [DOI]
4 Lapatinib nano-delivery systems: a promising future for breast cancer treatment
Gunjan Vasant Bonde,Sarita Kumari Yadav,Sheetal Chauhan,Pooja Mittal,Gufran Ajmal,Sathish Thokala,Brahmeshwar Mishra
Expert Opinion on Drug Delivery. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
5 The telomere-binding protein TRF2 is required for metronomic therapeutic effects of gemcitabine and capecitabine
Wei-Ping Lee,Keng-Hsin Lan,Chung-Pin Li,Yee Chao,Ming-Chih Hou,Han-Chieh Lin,Shou-Dong Lee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017; 1863(4): 917
[Pubmed]  [Google Scholar] [DOI]
6 The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field
T. B. Gaspar,J. Henriques,L. Marconato,F. L. Queiroga
Veterinary and Comparative Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 A Commentary: Herbal Medicine Offers Great Potential in Support of Metronomic Cancer Therapy
Clara Bik-San Lau,Chun-Kwok Wong,Ping-Chung Leung
Journal of Cancer Therapy. 2017; 08(02): 86
[Pubmed]  [Google Scholar] [DOI]
8 The novel roles of stromal fibroblasts in metronomic chemotherapy: Focusing on cancer stemness and immunity
Wen-Ying Liao,Tze-Sian Chan,Kelvin K. Tsai
Journal of Cancer Research and Practice. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study
R. M. Wouda,S. E. Hocker,M. L. Higginbotham
Veterinary and Comparative Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
10 Immunotherapy for the treatment of breast cancer
Mariela A. Moreno Ayala,Maria Florencia Gottardo,Antonela S. Asad,Camila Zuccato,Alejandro Nicola,Adriana Seilicovich,Marianela Candolfi
Expert Opinion on Biological Therapy. 2017; 17(7): 797
[Pubmed]  [Google Scholar] [DOI]
11 Metronomic chemotherapy for non-metastatic triple negative breast cancer: Selection is the key
Connie Rabanal,Rossana Ruiz,Silvia Neciosup,Henry Gomez
World Journal of Clinical Oncology. 2017; 8(6): 437
[Pubmed]  [Google Scholar] [DOI]
12 Combinatorial immunotherapy strategies for hepatocellular carcinoma
Maria Tagliamonte,Annacarmen Petrizzo,Maria Lina Tornesello,Gennaro Ciliberto,Franco M Buonaguro,Luigi Buonaguro
Current Opinion in Immunology. 2016; 39: 103
[Pubmed]  [Google Scholar] [DOI]
13 A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma†
R. Finotello,J. Henriques,S. Sabattini,D. Stefanello,R. Felisberto,S. Pizzoni,R. Ferrari,L. Marconato
Veterinary and Comparative Oncology. 2016; : n/a
[Pubmed]  [Google Scholar] [DOI]
14 Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model
Amr S. Abu Lila,Naoto Moriyoshi,Masakazu Fukushima,Cheng-Long Huang,Hiromi Wada,Tatsuhiro Ishida
Cancer Letters. 2016;
[Pubmed]  [Google Scholar] [DOI]
15 Cancer vaccines for hepatocellular carcinoma: future directions
Franco M Buonaguro,Luigi Buonaguro
Immunotherapy. 2016; 8(4): 391
[Pubmed]  [Google Scholar] [DOI]
16 Refractory Choriocarcinoma: Complete Response With Oral Etoposide
Manikandan Dhanushkodi,Trivadi Ganesan,Tenali Gnana Sagar
Journal of Global Oncology. 2016; : JGO006049
[Pubmed]  [Google Scholar] [DOI]
17 Metronomic chemotherapy and nanocarrier platforms
Amr S. Abu Lila,Tatsuhiro Ishida
Cancer Letters. 2016;
[Pubmed]  [Google Scholar] [DOI]
18 Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells
Ursula Winter,Hebe A. Mena,Soledad Negrotto,Eloisa Arana,Guillem Pascual-Pasto,Viviana Laurent,Mariona Suñol,Guillermo L. Chantada,Angel M. Carcaboso,Paula Schaiquevich,Francesco Bertolini
PLOS ONE. 2016; 11(7): e0160094
[Pubmed]  [Google Scholar] [DOI]
19 Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer
Roberto Petrioli,Giandomenico Roviello,Anna Ida Fiaschi,Letizia Laera,Salvatora Tindara Miano,Daniele Marrelli,Franco Roviello,Vincenzo Bianco,Edoardo Francini
Future Oncology. 2015; 11(18): 2563
[Pubmed]  [Google Scholar] [DOI]
20 From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
Karolina Vernmark,Maria Albertsson,Bergthor Björnsson,Thomas Gasslander,Per Sandström,Xiao-Feng Sun,Annika Holmqvist
BMC Cancer. 2015; 15(1)
[Pubmed]  [Google Scholar] [DOI]
21 Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
Irina Kareva,David J. Waxman,Giannoula Lakka Klement
Cancer Letters. 2015; 358(2): 100
[Pubmed]  [Google Scholar] [DOI]
22 Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma
Zeng Wang-Yuan,Zeng Jiang-Zheng,Yan-Da Lu,Xin-Bao Hao,Tao Hong,Fen Huang,Jun-Hua Lei,Zhi-Hui He,Mei-zhu Huang
International Journal of Hyperthermia. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
23 Head and neck cancer: metronomic chemotherapy
Francesca De Felice,Daniela Musio,Vincenzo Tombolini
BMC Cancer. 2015; 15(1)
[Pubmed]  [Google Scholar] [DOI]
24 Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
Gabriella Ferrandina,Giacomo Corrado,Floriana Mascilini,Paola Malaguti,Riccardo Samaritani,Mariagrazia Distefano,Valeria Masciullo,Alessia Di Legge,Antonella Savarese,Giovanni Scambia
BMC Cancer. 2014; 14(1): 947
[Pubmed]  [Google Scholar] [DOI]


Read this article